eXoZymes, Inc. 是一家处于开发阶段的合成生化公司。公司总部位于加利福尼亚州莫农维亚,并拥有31名全职员工。该公司于2024年11月13日上市。该公司开发了一个平台,提供控制和优化自然界自身生物过程的工具和见解,使合作伙伴能够用新的可持续且无污染的替代方法取代传统的化学生产方法。Exozymes是利用人工智能工程技术开发的先进酶类,能够在活细胞之外的生物反应器中旺盛生长。
EXOZ stock price ended at $10.43 on 星期一, after dropping 0.76%
On the latest trading day Feb 09, 2026, the stock price of EXOZ fell by 0.76%, dropping from $10.37 to $10.43. During the session, the stock saw a volatility of 1.06%, with prices oscillating between a daily low of $10.37 and a high of $10.48. On the latest trading day, the trading volume for EXOZ rose by 1.2K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 2.1K shares were traded, with a market value of approximately $87.5M.